Expanded Milan criteria on pathological examination after liver transplantation: analysis of preoperative data

I F S F Boin1, E M Pracucho, M C Rique

  • 1Unit of Liver Transplantation, Hospital de Clínicas, State University of Campinas, São Paulo, Brazil. ilkaboin@yahoo.com

Abstract

Insights

Imaging techniques often underestimate hepatocellular carcinoma (HCC) tumors, but survival after liver transplantation remains similar for patients meeting Milan Criteria (MC) and Expanded Milan Criteria (EMC). This highlights the importance of considering factors beyond initial imaging for HCC patient outcomes.

Area of Science:

  • Hepatobiliary Surgery
  • Transplant Surgery
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) management relies on accurate staging for liver transplantation eligibility.
  • The Milan Criteria (MC) are widely used, but Expanded Milan Criteria (EMC) may include more patients.
  • Evaluating preoperative imaging accuracy against explant histology is crucial for patient selection and outcomes.

Purpose of the Study:

  • To assess the accuracy of imaging techniques (ultrasound and CT) in relation to the Milan Criteria (MC) and Expanded Milan Criteria (EMC).
  • To compare explant histology with preoperative imaging findings for hepatocellular carcinoma (HCC).
  • To analyze the impact of these criteria and imaging accuracy on patient survival after liver transplantation.

Main Methods:

  • A retrospective analysis of 45 cirrhotic patients with HCC who underwent liver transplantation between 1997 and 2006.
  • Patients were categorized into MC and EMC groups based on explant histology.
  • Preoperative imaging (US/CT), tumor characteristics, alpha-fetoprotein (AFP) levels, and vascular invasion were compared to assess prognostic value for survival.

Main Results:

  • 42.2% of explants met the Expanded Milan Criteria (EMC) but were not identified preoperatively.
  • Imaging sensitivity was 83.3% for CT and 75% for US; specificity was 96% for CT and 80.1% for US.
  • Ten-year survival rates were 57.77% for MC patients and 47.4% for EMC patients, with similar outcomes despite underestimated tumor burden in EMC group.

Conclusions:

  • Preoperative imaging frequently underestimates tumor burden in HCC patients, with ~42.2% falling into EMC but not MC.
  • Despite underestimation, patients meeting EMC criteria showed similar 10-year survival rates to those meeting MC criteria.
  • These findings suggest that factors beyond strict adherence to MC imaging may support successful liver transplantation outcomes in HCC.